Michael A. Gollin

home / authors / michael-gollin

Articles

Myriad Decision Places Biotech at a Crossroads

Rae Fischer;Michael A. Gollin

August 1st 2010

In light of the new ruling, patent licensees may want to re-evaluate the strength of their licensed patents.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

3D rendered laboratory test tubes with fluorescent green positive results in uv light | Image Credit: ©mguido - stock.adobe.com

Published: July 16th 2025 | Updated: July 18th 2025

Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation

Syringe aimed at the center of a target. Pharmacogenetics concept, symbolizing precise drug delivery based on genetic profiles. Low poly style | Image Credit: ©Елена Бутусова -stock.adobe.com

Published: July 4th 2025 | Updated: July 18th 2025

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

BIO 2025: Speeding Up Development of Next-Generation Biologics

Published: June 23rd 2025 | Updated: July 18th 2025

BIO 2025: Speeding Up Development of Next-Generation Biologics

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.